{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:09Z","timestamp":1788873189986,"version":"build-2803163510"},"reference-count":180,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1106600"],"award-info":[{"award-number":["2022YFA1106600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273255"],"award-info":[{"award-number":["82273255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81821002"],"award-info":[{"award-number":["81821002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81822034"],"award-info":[{"award-number":["81822034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325039"],"award-info":[{"award-number":["82325039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bbcan.2025.189346","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:25:33Z","timestamp":1746530733000},"page":"189346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deciphering the \u201cRosetta Stone\u201d of ovarian cancer stem cells: Opportunities and challenges"],"prefix":"10.1016","volume":"1880","author":[{"given":"Jixue","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.bbcan.2025.189346_bb0005","first-page":"284","article-title":"Ovarian cancer statistics","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2025.189346_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.936","article-title":"The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer","volume":"5","author":"Mazidimoradi","year":"2022","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","article-title":"Cancer stem cells","volume":"355","author":"Jordan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0020","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.3390\/cancers13164178","article-title":"Ovarian Cancer and Cancer stem cells\u2014cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and oncology","volume":"13","author":"Nowicki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0030","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/cancers14092311","article-title":"A novel estrogen receptor \u03b2 agonist diminishes ovarian cancer stem cells via suppressing the epithelial-to-mesenchymal transition","volume":"14","author":"Banerjee","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-023-03244-4","article-title":"Targeting ovarian cancer stem cells: a new way out","volume":"14","author":"Ma","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbcan.2025.189346_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02318-8","article-title":"RNA m6A methylation regulators in ovarian cancer","volume":"21","author":"Guo","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189346_bb0045","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3390\/cancers12051267","article-title":"Metabolic plasticity in ovarian cancer stem cells","volume":"12","author":"Ghoneum","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","article-title":"Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles","volume":"43","author":"Yousefi","year":"2020","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbcan.2025.189346_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189346_bb0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/0008-5472.CAN-20-1488","article-title":"Frizzled-7 identifies platinum-tolerant ovarian cancer cells susceptible to ferroptosis","volume":"81","author":"Wang","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0065","article-title":"The epithelial-mesenchymal transcription factor snai1 represses transcription of the tumor suppressor mirna let-7 in cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0070","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1111\/cas.15100","article-title":"Loss of Kruppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1\/slug signaling","volume":"112","author":"Wang","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0075","article-title":"BMP signaling is a therapeutic target in ovarian cancer","volume":"6","author":"Fukuda","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0080","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/s41388-021-01913-3","article-title":"ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers","volume":"40","author":"Li","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189346_bb0085","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12015-019-09911-5","article-title":"PTTG1: a unique regulator of stem\/cancer stem cells in the ovary and ovarian cancer","volume":"15","author":"Parte","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0090","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1111\/jcmm.17557","article-title":"NANOG regulates epithelial-mesenchymal transition via AMPK\/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells","volume":"26","author":"Yun","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0095","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.3390\/cancers14194851","article-title":"FOXC2 promotes vasculogenic mimicry in ovarian cancer","volume":"14","author":"Recouvreux","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s12885-019-5824-9","article-title":"Inhibition of PI3K\/Akt\/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression","volume":"19","author":"Deng","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0105","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.2147\/IJN.S380598","article-title":"Salinomycin-loaded high-density lipoprotein exerts promising anti-ovarian cancer effects by inhibiting epithelial-mesenchymal transition","volume":"17","author":"Zou","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189346_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41568-021-00332-6","article-title":"Linking EMT programmes to normal and neoplastic epithelial stem cells","volume":"21","author":"Lambert","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Ds","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0125","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/cancers11071008","article-title":"The role of cancer stem cells and mechanical forces in ovarian cancer metastasis","volume":"11","author":"Bregenzer","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0130","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Liao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189346_bb0135","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.7150\/thno.70194","article-title":"SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells","volume":"12","author":"Xuan","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189346_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41416-020-0865-z","article-title":"Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3\/AKT\/NF-\u03baB\/IL-8 signalling in ovarian cancer","volume":"123","author":"Jiang","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0145","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/cells9051218","article-title":"Circulating tumor cells characterization revealed timp1 as a potential therapeutic target in ovarian cancer","volume":"9","author":"Abreu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189346_bb0150","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.bbcan.2025.189346_bb0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.gendis.2020.11.017","article-title":"Revisiting chemoresistance in ovarian cancer: mechanism, biomarkers, and precision medicine","volume":"9","author":"Guo","year":"2022","journal-title":"Genes Dis"},{"key":"10.1016\/j.bbcan.2025.189346_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216437","article-title":"Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer","volume":"578","author":"Dogra","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189346_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-021-00726-x","article-title":"The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence","volume":"19","author":"Wesley","year":"2021","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.bbcan.2025.189346_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119076","article-title":"Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway","volume":"1868","author":"Wang","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12967-022-03447-y","article-title":"Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer","volume":"20","author":"Sriramkumar","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0180","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/cancers15041275","article-title":"An overview of ovarian cancer: the role of cancer stem cells in chemoresistance and a precision medicine approach targeting the wnt pathway with the antagonist sFRP4","volume":"15","author":"Varier","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12964-024-01585-y","article-title":"Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1","volume":"22","author":"Xia","year":"2024","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.bbcan.2025.189346_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.707424","article-title":"HOTTIP-miR-205-ZEB2 axis confers cisplatin resistance to ovarian cancer cells","volume":"9","author":"Dong","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41419-023-06076-5","article-title":"HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway","volume":"14","author":"Han","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-1130-z","article-title":"Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness","volume":"19","author":"Mu\u00f1oz-Galv\u00e1n","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0205","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.32293","article-title":"Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway","volume":"145","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0210","first-page":"57","article-title":"Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors","volume":"43","author":"Mu\u00f1oz-Galv\u00e1n","year":"2024","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0215","first-page":"234","article-title":"New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools","volume":"38","author":"Mu\u00f1oz-Galv\u00e1n","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0220","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/cells10040918","article-title":"Repositioning Trimebutine maleate as a Cancer treatment targeting ovarian Cancer stem cells","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189346_bb0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1541-7786.MCR-22-0486","article-title":"TWEAK-Fn14-RelB signaling Cascade promotes stem cell-like features that contribute to post-chemotherapy ovarian Cancer relapse","volume":"21","author":"Holmberg","year":"2023","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41419-020-03009-4","article-title":"Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness","volume":"11","author":"Karvonen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0235","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.33398","article-title":"Epigenetic regulation of cancer stem cell formation and maintenance","volume":"148","author":"French","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13235993","article-title":"Epigenetic mechanisms and therapeutic targets in chemoresistant high-grade serous ovarian cancer","volume":"13","author":"Matthews","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0245","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41467-019-09144-7","article-title":"Chronic Chlamydia infection in human organoids increases stemness and promotes age-dependent CpG methylation","volume":"10","author":"Kessler","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189346_bb0250","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41388-022-02311-z","article-title":"H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity","volume":"41","author":"He","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189346_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119077","article-title":"BAG3 epigenetically regulates GALNT10 expression via WDR5 and facilitates the stem cell-like properties of platin-resistant ovarian cancer cells","volume":"1868","author":"Zhao","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118878","article-title":"m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells","volume":"1868","author":"Hao","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0265","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-19-4044","article-title":"FTO-dependent N6-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking camp signaling","volume":"80","author":"Huang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0270","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/cancers15041033","article-title":"The emerging role of m6A modification in endocrine Cancer","volume":"15","author":"Ji","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0275","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1002\/jcp.26060","article-title":"MicroRNA-mediated drug resistance in ovarian cancer","volume":"234","author":"Mihanfar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0280","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41420-024-01858-y","article-title":"CD24 induced cellular quiescence-like state and chemoresistance in ovarian cancer cells via miR-130a\/301a-dependent CDK19 downregulation","volume":"10","author":"Jang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122224","article-title":"Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells","volume":"334","author":"Ravindran","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0290","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3390\/cancers13184617","article-title":"Let-7i reduces aggressive phenotype and induces BRCAness in ovarian cancer cells","volume":"13","author":"Chirshev","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110085","article-title":"Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level","volume":"126","author":"Qian","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189346_bb0300","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.7150\/ijbs.83264","article-title":"Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling","volume":"19","author":"Zou","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0305","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-18-3668","article-title":"Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer","volume":"79","author":"Srivastava","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0310","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/0008-5472.CAN-20-2041","article-title":"The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer","volume":"81","author":"Belur Nagaraj","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0315","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/cells8080840","article-title":"Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies","volume":"8","author":"Khan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189346_bb0320","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12935-021-02019-2","article-title":"LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt\/\u03b2-catenin pathway through competitively binding to microRNA-30a","volume":"21","author":"Hou","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189346_bb0325","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/cells11030363","article-title":"Stem cell factor SOX9 interacts with a cell death regulator RIPK1 and results in escape of cancer stem cell death","volume":"11","author":"Oh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189346_bb0330","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166723","article-title":"Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy","volume":"1869","author":"Sohn","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0340","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/cam4.1975","article-title":"BRCA1 affects the resistance and stemness of SKOV3-derived ovarian cancer stem cells by regulating autophagy","volume":"8","author":"You","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121384","article-title":"Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt \u03b2-catenin pathway, disrupting the interaction between \u03b2-catenin and CD24 and suppressing autophagy","volume":"316","author":"Sundaram","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0350","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/cancers14061399","article-title":"Metabolic reprogramming of ovarian cancer spheroids during adhesion","volume":"14","author":"Compton","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2019.04.003","article-title":"Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells","volume":"57","author":"Li","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13578-019-0293-z","article-title":"Modulation of lipolysis and glycolysis pathways in cancer stem cells changed multipotentiality and differentiation capacity toward endothelial lineage","volume":"9","author":"Pouyafar","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0365","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cancers11060813","article-title":"Hexokinase 2 regulates ovarian cancer cell migration, invasion and sternness via FAK\/ERK1\/2\/MMP9\/NANOG\/SOX9 signaling cascades","volume":"11","author":"Siu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0370","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/cancers11111678","article-title":"The metabolic inhibitor CPI-613 negates treatment enrichment of ovarian cancer stem cells","volume":"11","author":"Bellio","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0375","doi-asserted-by":"crossref","first-page":"21382","DOI":"10.1038\/s41598-023-48485-8","article-title":"Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0380","article-title":"Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells","volume":"6","author":"Artibani","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2025.189346_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081083","article-title":"The role of intra-tumoral heterogeneity and its clinical relevance in epithelial ovarian cancer recurrence and metastasis","volume":"11","author":"Roberts","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0390","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.3390\/cancers15174419","article-title":"Human aldehyde dehydrogenases: a superfamily of similar yet different proteins highly related to cancer","volume":"15","author":"Xanthis","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0395","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/cancers12040961","article-title":"Targeting aldehyde dehydrogenases to eliminate cancer stem cells in gynecologic malignancies","volume":"12","author":"Muralikrishnan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0400","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189346_bb0405","first-page":"159","article-title":"ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR\/mTOR-PI3K\/aurora kinase inhibitors","volume":"116","author":"Huang","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2025.189346_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143437","article-title":"A novel ALDH1A1 inhibitor blocks platinum-induced senescence and stemness in ovarian cancer","volume":"14","author":"Muralikrishnan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0415","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cancers11040502","article-title":"A novel ALDH1A1 inhibitor targets cells with stem cell characteristics in ovarian cancer","volume":"11","author":"Nwani","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110910","article-title":"Development of substituted benzimidazoles as inhibitors of human aldehyde dehydrogenase 1A isoenzymes","volume":"391","author":"Takahashi","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbcan.2025.189346_bb0425","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","article-title":"A pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells","volume":"26","author":"Chefetz","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109371","article-title":"Inhibitory effect on ovarian cancer ALDH plus stem-like cells by disulfiram and copper treatment through ALDH and ROS modulation","volume":"118","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189346_bb0435","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1002\/stem.236","article-title":"CD133 expression defines a tumor initiating cell population in primary human ovarian cancer","volume":"27","author":"Curley","year":"2009","journal-title":"Stem Cells Dayt. Ohio"},{"key":"10.1016\/j.bbcan.2025.189346_bb0440","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","article-title":"Expression of CD133-1 and CD133-2 in ovarian cancer","volume":"18","author":"Ferrandina","year":"2008","journal-title":"Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc."},{"key":"10.1016\/j.bbcan.2025.189346_bb0445","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/cancers16010040","article-title":"The role of cancer stem cell markers in ovarian cancer","volume":"16","author":"Fr\u0105szczak","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12015-018-9865-2","article-title":"Integrative analysis of CD133 mRNA in human cancers based on data mining","volume":"15","author":"Wen","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0455","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10585-012-9482-4","article-title":"CD44+\/CD24\u2212 ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival","volume":"29","author":"Meng","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2025.189346_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146186","article-title":"Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling","volume":"131","author":"Qian","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189346_bb0465","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/ijms12021009","article-title":"Role of versican, hyaluronan and CD44 in ovarian cancer metastasis","volume":"12","author":"Ween","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0470","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/cancers12041013","article-title":"Correlation of PKM2 and CD44 protein expression with poor prognosis in platinum-treated epithelial ovarian cancer: a retrospective study","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0475","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-14-0607","article-title":"CD24+ ovarian cancer cells are enriched for cancer-initiating cells and dependent on JAK2 signaling for growth and metastasis","volume":"14","author":"Burgos-Ojeda","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189346_bb0480","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrc.2013.01.102","article-title":"CD24+ ovary cancer cells exhibit an invasive mesenchymal phenotype","volume":"432","author":"Kang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189346_bb0485","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Gao","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189346_bb0490","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01315-w","article-title":"Targeting CD24 as a novel immunotherapy for solid cancers","volume":"21","author":"Yang","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2025.189346_bb0495","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-022-09953-y","article-title":"CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells","volume":"22","author":"Yin","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0500","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers12010217","article-title":"L1 cell adhesion molecule confers radioresistance to ovarian cancer and defines a new cancer stem cell population","volume":"12","author":"Terraneo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0505","doi-asserted-by":"crossref","first-page":"1057484","DOI":"10.3389\/fcell.2023.1057484","article-title":"Expression level of CD117 (KIT) on ovarian cancer extracellular vesicles correlates with tumor aggressiveness","volume":"11","author":"Shnaider","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.02.002","article-title":"Ovarian cancer stem cell markers: prognostic and therapeutic implications","volume":"322","author":"Burgos-Ojeda","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189346_bb0515","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/cancers14153580","article-title":"Identification of malignant cell populations associated with poor prognosis in high-grade serous ovarian cancer using single-cell rna sequencing","volume":"14","author":"Sumitani","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0520","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.stem.2012.02.016","article-title":"Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells","volume":"10","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2025.189346_bb0525","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ygyno.2019.03.099","article-title":"SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma","volume":"153","author":"Sherman-Samis","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0530","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/cancers13020262","article-title":"Characterization of SOX2, OCT4 and NANOG in ovarian cancer tumor-initiating cells","volume":"13","author":"Robinson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0535","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0540","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189346_bb0545","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1111\/cas.15940","article-title":"Adipocyte regulation of cancer stem cells","volume":"114","author":"Khaledian","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0550","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12967-023-04575-9","article-title":"Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0555","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189346_bb0560","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","article-title":"Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance","volume":"80","author":"Mukherjee","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0565","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10495-016-1339-x","article-title":"Adipocyte microenvironment promotes Bclxl expression and confers chemoresistance in ovarian cancer cells","volume":"22","author":"Cardenas","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbcan.2025.189346_bb0570","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0575","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-023-00495-5","article-title":"Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling","volume":"8","author":"Fang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0580","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.3390\/ijms23095120","article-title":"Epigenomic profiling of epithelial ovarian cancer stem-cell differentiation reveals gpd1 associated immune suppressive microenvironment and poor prognosis","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0585","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41419-019-1656-4","article-title":"A juxtacrine\/paracrine loop between C-kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer","volume":"10","author":"Mazzoldi","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189346_bb0590","first-page":"270","article-title":"UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer","volume":"42","author":"Harrington","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0595","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ijc.34421","article-title":"Cancer stem cell-immune cell collusion in immunotherapy","volume":"153","author":"Wang","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030757","article-title":"Innate immune program in formation of tumor-initiating cells from cells-of-origin of breast, prostate, and ovarian cancers","volume":"15","author":"Han","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.637675","article-title":"The role of tumor-stroma interactions in drug resistance within tumor microenvironment","volume":"9","author":"Ni","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0610","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0615","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40425-019-0666-1","article-title":"Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments","volume":"7","author":"Raghavan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0620","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s00018-023-04972-9","article-title":"Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer","volume":"80","author":"Price","year":"2023","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.bbcan.2025.189346_bb0625","doi-asserted-by":"crossref","first-page":"1803530","DOI":"10.1080\/2162402X.2020.1803530","article-title":"Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells","volume":"9","author":"Chang","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2025.189346_bb0630","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell-immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.665970","article-title":"PTK7-targeting CAR T-cells for the treatment of lung Cancer and other malignancies","volume":"12","author":"Jie","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0640","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135038","article-title":"Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade","volume":"131","author":"Sehgal","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189346_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114547","article-title":"Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination","volume":"161","author":"Xu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189346_bb0650","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","article-title":"Targeting cancer stem cell pathways for cancer therapy","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2025.189346_bb0655","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/cells8080812","article-title":"Molecular mechanisms associated with ROR1-mediated drug resistance: crosstalk with Hippo-YAP\/TAZ and BMI-1 pathways","volume":"8","author":"Karvonen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189346_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/ERC-18-0300","article-title":"CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells","volume":"26","author":"Lin","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0665","article-title":"Aryl hydrocarbon receptor (AhR) promotes cell growth, induces Stemness like characteristics and metastasis in ovarian Cancer cells via activation of Akt, \u03b2-catenin and EMT","volume":"36","author":"Therachiyil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189346_bb0670","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12935-019-0780-7","article-title":"Stimulative role of ST6GALNAC1 in proliferation, migration and invasion of ovarian cancer stem cells via the Akt signaling pathway","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2025.189346_bb0675","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-022-09807-7","article-title":"PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis","volume":"22","author":"Sohn","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0680","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.7150\/thno.48101","article-title":"EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells","volume":"11","author":"Wen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189346_bb0685","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13287-021-02256-2","article-title":"EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1\/KLF4 axis","volume":"12","author":"Kun Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbcan.2025.189346_bb0690","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.7150\/thno.33444","article-title":"Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3","volume":"9","author":"Lu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189346_bb0695","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12964-023-01172-7","article-title":"HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK\/ERK signaling pathway","volume":"21","author":"Ma","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bbcan.2025.189346_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123692","article-title":"ZIP4 is a novel cancer stem cell marker in high-grade serous ovarian cancer","volume":"12","author":"Fan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110688","article-title":"The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway","volume":"107","author":"Yang","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2025.189346_bb0710","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12967-019-2005-1","article-title":"SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway","volume":"17","author":"Zhu","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0715","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2021.12.029","article-title":"TRIM29 regulates the SETBP1\/SET\/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer","volume":"529","author":"Qiao","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2025.189346_bb0720","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151591","article-title":"FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway","volume":"132","author":"Zhang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189346_bb0725","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1158\/0008-5472.CAN-20-0458","article-title":"EZH2-mediated downregulation of the tumor suppressor DAB2IP maintains ovarian cancer stem cells","volume":"80","author":"Zong","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0730","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1158\/1541-7786.MCR-22-0418","article-title":"DOT1 L regulates ovarian cancer stem cells by activating \u03b2-catenin signaling","volume":"21","author":"Zhang","year":"2023","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0735","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1038\/s41598-022-18662-2","article-title":"TWIST1 induces proteasomal degradation of \u03b2-catenin during the differentiation of ovarian cancer stem-like cells","volume":"12","author":"Liu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189346_bb0740","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/cancers11091228","article-title":"Keratin-14 (KRT14) positive leader cells mediate mesothelial clearance and invasion by ovarian cancer cells","volume":"11","author":"Bilandzic","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0745","first-page":"265","article-title":"KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer","volume":"39","author":"De Donato","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0750","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e46","article-title":"SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells","volume":"31","author":"Yue","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0755","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1111\/jcmm.16503","article-title":"ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189346_bb0760","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/jcp.29220","article-title":"Isolation and phenotypic characterization of tumor cells of patients with a diagnosis of ovarian cancer","volume":"235","author":"Guti\u00e9rrez-Casta\u00f1eda","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101015","article-title":"3D bioprinted cancer models: revolutionizing personalized cancer therapy","volume":"14","author":"Augustine","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0770","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ijc.33983","article-title":"Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities","volume":"151","author":"Lupia","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0775","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/thno.37423","article-title":"WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer","volume":"10","author":"Kotrbov\u00e1","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bbcan.2025.189346_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101477","article-title":"Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids","volume":"24","author":"Suraiya","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0785","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1158\/0008-5472.CAN-17-3993","article-title":"Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties","volume":"78","author":"Hirst","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0790","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/cancers12102727","article-title":"Promising applications of tumor spheroids and organoids for personalized medicine","volume":"12","author":"Gilazieva","year":"2020","journal-title":"CANCERS"},{"key":"10.1016\/j.bbcan.2025.189346_bb0795","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1186\/s12885-022-10042-3","article-title":"An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0800","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2019.05.005","article-title":"Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors","volume":"154","author":"Maru","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0805","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1021\/acsbiomaterials.9b01967","article-title":"Expansion of ovarian cancer stem-like cells in poly(ethylene glycol)-cross-linked poly(methyl vinyl ether-alt-maleic acid) and alginate double-network hydrogels","volume":"6","author":"Zhou","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbcan.2025.189346_bb0810","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/labinvest.2013.92","article-title":"Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century","volume":"93","author":"Williams","year":"2013","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030699","article-title":"The capacity of high-grade serous ovarian cancer cells to form multicellular structures spontaneously along disease progression correlates with their orthotopic tumorigenicity in immunosuppressed mice","volume":"12","author":"Goyeneche","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0820","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.5521","article-title":"Phase 1\/1b study of the FAK inhibitor defactinib (VS-6063) in combination with weekly paclitaxel for advanced ovarian cancer","author":"Patel","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0825","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.21.01801","article-title":"Phase Ib study of navicixizumab plus paclitaxel in patients with platinum-resistant ovarian, primary peritoneal, or fallopian tube cancer","volume":"40","author":"Fu","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2025.189346_bb0830","article-title":"Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer","volume":"5","author":"Brown","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2025.189346_bb0835","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.3390\/cancers13133196","article-title":"Maximum tolerated dose and anti-tumor activity of intraperitoneal cantrixil (TRX-E-002-1) in patients with persistent or recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: phase I study results","volume":"13","author":"Coward","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0840","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cncr.23605","article-title":"Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis\u00a0: a Hoosier oncology group trial","volume":"113","author":"Matei","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0845","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41416-019-0649-5","article-title":"FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer","volume":"122","author":"Annett","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189346_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114350","article-title":"Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA\/YAP axis","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189346_bb0855","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/cancers13061369","article-title":"The MEK1\/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma","volume":"13","author":"Chesnokov","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0860","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1541-7786.MCR-18-0409","article-title":"SPHK1 is a novel target of metformin in ovarian cancer","volume":"17","author":"Hart","year":"2019","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0865","doi-asserted-by":"crossref","first-page":"103297","DOI":"10.1016\/j.isci.2021.103297","article-title":"Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy","volume":"24","author":"Shen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2025.189346_bb0870","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s13402-020-00504-w","article-title":"The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary","volume":"43","author":"Sneha","year":"2020","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbcan.2025.189346_bb0875","first-page":"1175","article-title":"Preclinical evaluation of NTX-301, a novel dna hypomethylating agent in ovarian cancer, Clin. Cancer res. Off. J. Am. Assoc","volume":"30","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189346_bb0880","first-page":"382","article-title":"Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway","volume":"38","author":"Islam","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.bbcan.2025.189346_bb0885","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1158\/1535-7163.MCT-16-0005","article-title":"TRX-E-002-1 induces c-Jun-dependent apoptosis in ovarian cancer stem cells and prevents recurrence in vivo","volume":"15","author":"Alvero","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2025.189346_bb0890","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3390\/cancers13123052","article-title":"The enhanced efficacy of intracellular delivery of doxorubicin\/c6-ceramide combination mediated by the F3 peptide\/nucleolin system is supported by the downregulation of the PI3K\/Akt pathway","volume":"13","author":"Cruz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189346_bb0895","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.2147\/IJN.S217338","article-title":"Echogenic PEGylated PEI-loaded microbubble as efficient gene delivery system","volume":"14","author":"Chun","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bbcan.2025.189346_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189104","article-title":"Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications","volume":"1879","author":"Loda","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:36:17Z","timestamp":1778214977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":180,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0304419X25000885"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189346","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the \u201cRosetta Stone\u201d of ovarian cancer stem cells: Opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189346"}}